Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01418001
Title Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

sarcoma

Therapies

Docetaxel + Gemcitabine + Pazopanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.